19 results
Antifungal Polyenes - Amphoterecin B, Abelcet, Ambisome - Antibiotics Class Overview

Mechanism: binds ergosterol in membrane and
Antifungal Polyenes ... severe fungal infections ... #Pharmacology #Antibiotics ... #Review #Overview ... #Polyenes #Antifungal
Antifungal Echinocandins  - Antibiotics Class Overview

Mechanism: Inhibit glucan synthesis in fungal cell wall by blocking
Antifungal Echinocandins ... severe Candida infections ... for Aspergillus infections ... Anidulafungin #Pharmacology ... #Antibiotics #Review
Flutycosine - Antibiotics Class Overview
 - 
Mechanism: 5-FC interferes with DNA and protein synthesis.  Only
severe fungal infections ... severe candidal infections ... #Pharmacology #Antibiotics ... #Review #Overview ... #Flutycosine #Antifungal
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... Penicillium marneffei Infections ... Treating Acute Infection ... Penicilliosis #IDSA ... #HIVAIDS #pharmacology
Daptomycin  - Antibiotics Class Overview

Mechanism: Lipopeptide antibiotic – forms transmembrane channels and depolarizes cells.
and depolarizes cells ... skin/soft tissue infections ... cidal nature) #Pharmacology ... #Antibiotics #Review
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
IDSA Recommendations ... Infection in HIV-AIDS ... Infection General ... #IDSA #Prevention ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... Note: Systemic antifungals ... candida #mucosal #IDSA ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... CD4 count <200 cells ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
IDSA Recommendations ... Treating Mild Infections ... CD4 count <250 cells ... Coccidiodomycosis #IDSA ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
IDSA Recommendations ... Cytomegalovirus Infections ... CD4 count >100 cells ... Cytomegalovirus #CMV #IDSA ... #HIVAIDS #pharmacology